Krzysztof MARYCZ, Katarzyna BASINSKA, NEZİR YAŞAR TOKER, Agnieszka SMIESZEK, Jakub NICPON

The activity of IL-6 and TNF-α in adipose tissue and peripheral blood in horses suffering from equine metabolic syndrome (EMS)

Atların metabolik sendrom (EMS)’u aşırı obezite ve/veya bölgesel yağlanma ile karakterize, insülin direnci (IR) , ileri derecede veya aniden oluşmuş laminitis ile karakterize metabolik bir hastalıktır. EMS derslerinde, proinflamatuar sitokinlerin aşırı ekspresyonu ile oluşan sistemik inflamasyon uygulamada önemli rol oynadığı anlatılmaktadır. Bu çalışmanın amacı, adipoz dokuda sentezlenen ve periferal kanda bulunan, IL-6 ve TNF-α’nin EMS’li atlarda oluşan ilişkilerini incelemektir. Araştırmanın ana hedefine göre atlar esas olarak, iki gruba ayrıldı: Grup A (EMS atlar, n = 8) ve grup B (kilolu sağlıklı atlar, n = 8). Periferal kanda proinflamatuar sitokinlerinin konsantrasyonu ve bunların adipoz dokulardaki etkisi belirlenmiştir. EMS grubunun sonuçları, pek çok makrofaj ve lenfosit infiltrasyonu ve adipositlerin çaplarında artış (P

Atlarda metabolik sendrom (EMS) sancısında, adipoz dokuda ve periferal kanda IL-6 ve TNF-α nın aktivitesi

Equine metabolic syndrome (EMS) is a metabolic disorder characterized by excessive obesity and or/regional adiposity, insulin resistance (IR) and prior or current laminitis. In the course of the EMS, an important role exert systemic inflammation caused by excessive expression of proinflammatory cytokines. The aim of the current investigation was to examine relationships between expression IL-6 and TNF-α in adipose tissue and their concentration in peripheral blood in horses with EMS. On the basis of range of research procedures, horses were divided into two groups: group A (EMS horses, n=8) and group B (healthy horses with overweight, n=8). The concentration of the proinflammatory cytokines in the peripheral blood and their expression in the adipose tissue were determined. The results of the EMS group showed numerous macrophages and lymphocytes infiltration and increased diameters of adipocytes (P<0.05). The concentration of TNF-α in the serum of insulin-resistant horses was statistically higher compared to the healthy individuals. No significant differences were observed between the EMS horses and the control horses in the concentration of IL-6 in the serum. Moreover, our research revealed expression of investigated cytokines in adipose tissue. The results shows a higher expression of TNF-α in the EMS groups. What is more, macrophages infiltration were observed. In the case of IL-6, were detected the similar arrangement of this cytokines in adipocytes between both test groups. The study indicates the importance of pro-inflammatory proteins TNF- α in the equine metabolic syndrome.

PDF

___

1. Dugdale AH, Curtis GC, Cripps P, Harris PA, Argo CM: Effect of dietary restriction on body condition, composition and welfare of overweight and obese pony mares. Equine Vet J, 42, 600-610, 2010.
2. Persky S, Eccleston CP. Collette P: Impact of genetic causal information on medical students’ clinical encounters with an obese virtual patient: Health promotion and social stigma. Ann Behav Med, 41, 363-372, 2010.
3. Kosiorowska A, Puggaard L, Hedemann MS, Sehested S, Jensen SK, Kristensen NB, Kuropka P, Marycz K, Vestergaard M: Gastrointestinal development of dairy calves fed low- or high-starch concentrate at two milk allowances. ANIMAL, 5, 211-219, 2011.
4. Kania M, Mikołajewska D, Marycz K, Kobielarz M: Effect of diet on mechanical properties of horse’s hair. Acta Bioeng Biomech 11, 53-57, 2009.
5. Johnson PJ: The equine metabolic syndrome peripheral Cushing’s syndrome. Vet Clin North Am: Equine Pract, 18, 271-293, 2002.
6. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ: Equine metabolic syndrome. J Vet Intern Med, 23 (3): 467-475, 2010.
7. Vick MM, Adams AA, Murphy BA, Sessions DR, Horohov DW, Cook RF, Shelton BJ, Fitzger BP: Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci, 85, 1144-1155, 2007.
8. Treiber KH, Kronfeld DS, Hess TM, DVM, Byrd BM, Splan RK, Staniar WB: Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc, 228, 1538-1545, 2006.
9. Carter RA, Treiber KH, Geor RJ, Douglass L, Harris PA: Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyper- leptinaemia and generalised and localised obesity in a cohort of ponies. Equine Vet J, 41, 171-178, 2009.
10. Frank N, Elliott SB, Brandt LE, Keisler DH: Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. J Am Vet Med Assoc, 228, 1383-1390, 2006.
11. de Graaf-Roelfsema E: Glucose homeostasis and the enteroinsular axis in the horse: A possible role in equine metabolic syndrome. Vet J, Jan;199(1):11-18, 2014.
12. Robie SM, Janson CH, Smith SC, O’Connor JT Jr: Equine serum lipids: Serum lipids and glucose in Morgan and Thoroughbred horses and Shetland ponies. Am J Vet Res, 36, 1705-1708, 1975.
13. Frank N: Equine metabolic syndrome. Vet Clin North Am: Equine Pract, 27 (1): 73-92, 2011.
14. Ya-Xiong Tao: The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocrine Rev, 31, 506-543, 2010.
15. Gauff F, Patan-Zugaj B, Licka TF: Hyperinsulinaemia increases vascular resistance and endothelin-1 expression in the equine digit. Equine Vet J, 45, 613-618, 2013.
16. Nourian AR, Asplin KE, Mcgowan CM, Sillence MN, Pollitt CC: Equine laminitis: Ultrastructural lesions detected in ponies following hyperinsulinaemia. Equine Vet J, 41, 671-677, 2009.
17. Marycz K, Nezir YT, Czogała J, Michalak I, Nicpoń J, Grzesiak J: An ınvestigation of the elemental composition of horse hair affected by Equine Metabolic Syndrome (EMS) using SEM EDX and ICP-OES. J Anim Vet Adv, 12, 146-152,2013.
18. Carter RA, Geor RJ, Burton Staniar WB, Cubbit TA, Harris PA: Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. Vet J, 179, 204-210, 2009.
19. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB, Wilson PWF, Meigs JB: Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance. J Clin Endocrinol Metabol, 93 (8): 3165- 3172, 2008.
20. Fain JN: Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm, 74, 443-477 , 2006.
21. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol, 89 (6): 2548-2556, 2004.
22. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes, 46, 451-455, 1997.
23. Kishimoto T: Interleukin-6: Discovery of pleiotropic cytokine. Arthiritis Res Ther, 8 (Suppl 2): S2, 2006.
24. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 112 (12): 1796-1808, 2003.
25. Henneke DR, Potter GD, Kreider JL, Yeates BF: Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J, 15, 371-382, 1983.
26. Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT 4th: Laminitis and the equine metabolic syndrome. Vet Clin North Am: Equine Pract, 26 (2): 239-255, 2010.
27. Marycz K, Moll E, Grzesiak J: Influence of functional nutrients on insulin resistance in horses with equine metabolic syndrome. Pakistan Vet J, 2074-7764 (Online), 2013.
28. Kaliński K, Marycz K, Czogała J, Serwa E, Janeczek W: An application of scanning electron microscopy combined with roentgen microanalysis (SEM-EDS) in canine urolithiasis. J Elect Mic, 61, 47-55, 2012.
29. Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT 4th: Diabetes, insulin resistance, and metabolic syndrome in horses. J Diabetes Sci Technol, 6 (3): 534-540, 2012.
30. McGregor-Argo C: Appraising the portly pony: Body condition and adiposity. Vet J, 179 (2): 158-160, 2009.
31. Wyse CA, McNie KA, Tannahill VJ, Murray JK, Love S: Prevalence of obesity in riding horses in Scotland. Vet Rec, 162 (18): 590-591, 2008.
32. Johnson PJ, Wiedmeyer CE, Messer NT, Ganjam VK: Medical implications of obesity in horses - lessons for human obesity. J Diabetes Sci Technol, 3 (1): 163-174, 2009.
33. Greenberg AS, Obin MS: Obesity and the role of adipose tissue in inflammation and metabolism. Am Soc Clin Nutr, 83, 461-465, 2006.
34. Radin MJ, Sharkey LC, Holycross BJ: Adipokines: A review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Pathol, 38 (2): 136-156, 2009.
35. Antuna-Puente B, Feve B, Fellahi S, Bastard JP: Adipokines: The missing link between insulin resistance and obesity. Diabetes Metab, 34 (1): 2-11, 2008.
36. Vázquez-Vela ME, Torres N, Tovar AR: White adipose tissue as endocrine organ and its role in obesity. Arch Med Res, 39 (8): 715-728, 2008.
37. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 389 (6651): 610-614, 1997.
38. Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest, 34 (11): 766-773, 2004.
39. Holbrook TC, Tipton T, McFarlane D: Neutrophil and cytokine dysregulation in hyperinsulinemia obese horses. Vet Immunol Immunopathol, 145 (1-2): 283-289, 2012.
40. Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and insulin resistance. Mol Med, 14 (11-12): 741-751, 2008.